HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.

Abstract
Since its initiation in 1995, the African Program for Onchocerciasis Control (APOC) has had a substantial impact on the prevalence and burden of onchocerciasis through annual ivermectin mass treatment. Ivermectin is a broad-spectrum anti-parasitic agent that also has an impact on other co-endemic parasitic infections. In this study, we roughly assessed the additional impact of APOC activities on the burden of the most important off-target infections: soil-transmitted helminthiases (STH; ascariasis, trichuriasis, hookworm, and strongyloidiasis), lymphatic filariasis (LF), and scabies. Based on a literature review, we formulated assumptions about the impact of ivermectin treatment on the disease burden of these off-target infections. Using data on the number of ivermectin treatments in APOC regions and the latest estimates of the burden of disease, we then calculated the impact of APOC activities on off-target infections in terms of disability-adjusted life years (DALYs) averted. We conservatively estimated that between 1995 and 2010, annual ivermectin mass treatment has cumulatively averted about 500 thousand DALYs from co-endemic STH infections, LF, and scabies. This impact comprised approximately an additional 5.5% relative to the total burden averted from onchocerciasis (8.9 million DALYs) and indicates that the overall cost-effectiveness of APOC is even higher than previously reported.
AuthorsStanimira P Krotneva, Luc E Coffeng, Mounkaila Noma, Honorat G M Zouré, Lalle Bakoné, Uche V Amazigo, Sake J de Vlas, Wilma A Stolk
JournalPLoS neglected tropical diseases (PLoS Negl Trop Dis) Vol. 9 Issue 9 Pg. e0004051 ( 2015) ISSN: 1935-2735 [Electronic] United States
PMID26401658 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiparasitic Agents
  • Ivermectin
Topics
  • Africa (epidemiology)
  • Antiparasitic Agents (administration & dosage)
  • Disease Transmission, Infectious (prevention & control)
  • Helminthiasis (epidemiology)
  • Humans
  • Intestinal Diseases, Parasitic (epidemiology)
  • Ivermectin (administration & dosage)
  • Onchocerciasis (complications, drug therapy, epidemiology)
  • Prevalence
  • Scabies (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: